Skip to main content
INGN
NASDAQ Industrial Applications And Services

Inogen Announces Major $30M Share Repurchase Program Alongside First Positive Annual Adjusted EBITDA Since 2021

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$6.22
Mkt Cap
$158.547M
52W Low
$5.48
52W High
$11.94
52W Position info
14% above low
Off High info
48% below high
Rel. Volume info
3.0× avg
Market data snapshot near publication time

INGN is trading near its 52-week low of $5.48 (14% above the low) on elevated volume (3.0× avg).

Summary

Inogen reported a significant financial turnaround with positive Adjusted EBITDA for the full year 2025, the first time since 2021, and authorized a substantial $30 million share repurchase program, signaling strong confidence in its financial health and future.


Key Events · Financing and Capital Events · INGN

  • Significant Share Repurchase Program

    The Board of Directors authorized a share repurchase program for up to $30 million of outstanding common stock, representing approximately 18.9% of the company's market capitalization. This program is financed through cash flow and existing cash reserves and expires by December 31, 2027.

  • Return to Profitability

    Inogen achieved positive Adjusted EBITDA of $2.7 million for the full year 2025, marking the first positive result since 2021. This improvement was driven by material cost reductions and operational efficiencies.

  • Strong Balance Sheet

    The company ended 2025 with a robust balance sheet, reporting $120.9 million in cash, cash equivalents, marketable securities, and restricted cash, with no outstanding debt.

  • Modest Revenue Growth and 2026 Outlook

    Total revenue for the full year 2025 increased by 3.9% to $348.7 million. For the full year 2026, Inogen expects reported revenue in the range of $366 million to $373 million, reflecting approximately 6% growth at the midpoint, and remains committed to driving positive Adjusted EBITDA improvement.


Analysis · INGN · Industrial Applications And Services

This filing highlights a pivotal moment for Inogen, demonstrating a clear path to improved financial performance and a commitment to shareholder value. The achievement of positive Adjusted EBITDA for the full year 2025, after years of losses, indicates successful operational efficiencies and strategic execution. The accompanying $30 million share repurchase program, representing nearly 19% of the company's current market capitalization, is a highly material capital allocation decision. It underscores management's belief in the company's intrinsic value and strong balance sheet, which boasts $120.9 million in cash and no debt. While revenue growth remains modest, the focus on profitability and shareholder returns suggests a more mature and financially disciplined approach. Investors should view this as a strong vote of confidence from the board and a potential catalyst for stock performance.

At the time of this filing, INGN was trading at $6.22 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $158.5M. The 52-week trading range was $5.48 to $11.94. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INGN - Latest Insights

INGN
Jul 01, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.70
Real-time Price: $6.30 info
Change: -$0.400 (-6%) info
Market Cap: $173.818M info
INGN
Jun 11, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $6.30 info
Change: +$0.170 (+3%) info
Market Cap: $173.818M info
INGN
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $6.30 info
Change: -$0.720 (-10%) info
Market Cap: $173.818M info
INGN
May 07, 2026, 4:47 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $6.30 info
Change: -$0.750 (-11%) info
Market Cap: $173.818M info
INGN
May 07, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $6.30 info
Change: -$0.750 (-11%) info
Market Cap: $173.818M info